Insulet (PODD) Financials: History & Chart

Insulet Corp.(PODD)

Medical - Devices · Acton, MA

$135.33-1.16 (-0.85%)

Delayed quote: Sep 24, 2026, 12:20 PM EDT

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA

5,400 employees

www.insulet.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Ashley McEvoy

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	3.05B	801.70M	761.70M	783.80M	706.30M	649.10M	569.00M	597.50M	543.90M
Cost of Goods Sold	883.10M	239.10M	232.60M	215.20M	196.20M	196.90M	160.00M	166.60M	166.80M
Gross Profit	2.17B	562.60M	529.10M	568.60M	510.10M	452.20M	409.00M	430.90M	377.10M
Gross Profit Margin	71.1%	70.2%	69.5%	72.5%	72.2%	69.7%	71.9%	72.1%	69.3%
Total Operating Expenses	1.65B	432.90M	406.90M	422.30M	392.40M	331.10M	320.20M	321.60M	289.00M
Research & Development	345.90M	88.10M	89.70M	90.90M	77.20M	73.40M	59.60M	60.60M	54.90M
Selling, General & Administrative	1.31B	344.80M	317.20M	331.40M	315.20M	257.70M	260.60M	261.00M	234.10M
Operating Income (EBIT)	515.80M	129.70M	122.10M	146.30M	117.70M	121.10M	88.80M	109.30M	88.10M
Operating Margin	16.9%	16.2%	16.0%	18.7%	16.7%	18.7%	15.6%	18.3%	16.2%
Income Before Tax (EBT)	494.70M	118.70M	113.00M	140.20M	122.80M	28.40M	48.10M	111.30M	82.90M
Interest Income	22.80M	3.60M	4.90M	5.70M	8.60M	10.10M	10.30M	10.30M	10.50M
Interest Expense	63.40M	13.50M	14.70M	19.60M	15.60M	19.60M	9.20M	8.70M	12.30M
Other Income/Expense	-21.10M	-11.00M	-9.10M	-6.10M	5.10M	-92.70M	-40.70M	2.00M	-5.20M
Net Income	375.30M	95.00M	91.10M	101.60M	87.60M	22.50M	35.40M	100.70M	77.50M
Income Tax Expense	119.30M	23.70M	21.90M	38.50M	35.20M	5.90M	12.70M	10.60M	5.40M
Net Profit Margin	12.3%	11.8%	12.0%	13.0%	12.4%	3.5%	6.2%	16.9%	14.2%
EBITDA	621.30M	156.40M	148.30M	176.90M	139.70M	143.40M	110.50M	130.80M	109.40M
EBITDA Margin	20.3%	19.5%	19.5%	22.6%	19.8%	22.1%	19.4%	21.9%	20.1%
Depreciation & Amortization	105.50M	26.70M	26.20M	30.60M	22.00M	22.30M	21.70M	21.50M	21.30M
EPS Basic	5.36	1.37	1.30	1.45	1.24	0.32	0.50	1.44	1.11
EPS Diluted	5.35	1.37	1.30	1.44	1.24	0.32	0.50	1.39	1.08
Weighted Average Basic Shares	69.30M	69.30M	69.99M	70.36M	70.65M	70.33M	70.27M	70.16M	70.12M
Weighted Average Diluted Shares	69.40M	69.40M	70.20M	70.67M	70.66M	70.64M	74.11M	74.08M	73.95M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	2.71B	2.07B	1.70B	1.31B	1.10B	904.40M	738.20M	563.82M
Cost of Goods Sold	768.20M	625.90M	537.20M	499.70M	346.70M	322.10M	257.90M	193.66M
Gross Profit	1.94B	1.45B	1.16B	805.60M	752.10M	582.30M	480.30M	370.17M
Gross Profit Margin	71.6%	69.8%	68.3%	61.7%	68.4%	64.4%	65.1%	65.7%
Total Operating Expenses	1.47B	1.14B	939.90M	768.00M	626.10M	530.80M	430.30M	342.80M
Research & Development	301.10M	219.60M	205.00M	180.20M	160.10M	146.80M	132.30M	88.61M
Selling, General & Administrative	1.17B	917.20M	734.90M	587.80M	466.00M	384.00M	298.00M	248.00M
Operating Income (EBIT)	473.80M	308.90M	220.00M	37.60M	126.00M	51.50M	50.00M	27.40M
Operating Margin	17.5%	14.9%	13.0%	2.9%	11.5%	5.7%	6.8%	4.9%
Income Before Tax (EBT)	339.50M	300.20M	214.60M	9.80M	20.50M	9.70M	14.50M	5.20M
Interest Income	34.70M	39.50M	28.60M	9.30M	500K	3.00M	N/A	6.71M
Interest Expense	79.70M	42.70M	36.20M	36.00M	61.70M	48.10M	34.60M	22.20M
Other Income/Expense	-134.30M	-8.70M	-5.40M	-27.80M	-105.50M	-41.80M	-35.50M	-22.20M
Net Income	247.10M	418.30M	206.30M	4.60M	16.80M	6.80M	11.60M	3.29M
Income Tax Expense	92.40M	-118.10M	8.30M	5.20M	3.70M	2.90M	2.90M	1.90M
Net Profit Margin	9.1%	20.2%	12.2%	0.4%	1.5%	0.8%	1.6%	0.6%
EBITDA	586.90M	389.70M	292.80M	100.80M	183.40M	106.90M	77.90M	43.00M
EBITDA Margin	21.7%	18.8%	17.3%	7.7%	16.7%	11.8%	10.6%	7.6%
Depreciation & Amortization	113.10M	80.80M	72.80M	63.20M	57.40M	55.40M	27.90M	15.60M
EPS Basic	3.51	5.97	2.96	0.07	0.25	0.11	0.19	0.06
EPS Diluted	3.48	5.78	2.94	0.07	0.25	0.10	0.19	0.05
Weighted Average Basic Shares	70.35M	70.08M	69.75M	69.38M	67.70M	64.73M	60.59M	58.86M
Weighted Average Diluted Shares	71.89M	73.89M	73.63M	69.91M	68.58M	65.95M	62.30M	61.01M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.